Tactics of topical therapy for cutaneous vasculitis in rheumatoid arthritis


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

One of the extra-articular systemic manifestations of rheumatoid arthritis (RA) is cutaneous rheumatoid vasculitis (RV). Among the reasons for the development of RV, an important place is occupied by the deposition of immune complexes in the walls of blood vessels. This concept is based on the detection of high titers of rheumatoid factor, circulating immune complexes, as well as cryoglobulins in most RA patients with RV. Along with the use of disease-modifying anti-rheumatic drug therapy, topical treatment plays a significant role.

Толық мәтін

Рұқсат жабық

Авторлар туралы

David Bestaev

North Ossetian State Medical Academy

Email: davidbestaev@rambler.ru
MD, Head of the Department of Internal Diseases № 3 Vladikavkaz, Russia

S. Ktsoeva

North Ossetian State Medical Academy

Vladikavkaz, Russia

Z. Brtsieva

North Ossetian State Medical Academy

Vladikavkaz, Russia

L. Khutieva

North Ossetian State Medical Academy

Vladikavkaz, Russia

L. Osipova

North Ossetian State Medical Academy

Vladikavkaz, Russia

N. Burduli

North Ossetian State Medical Academy

Vladikavkaz, Russia

O. Kotsoeva

North Ossetian State Medical Academy

Vladikavkaz, Russia

T. Bestaeva

Family Medicine Clinic

Vladikavkaz, Russia

Әдебиет тізімі

  1. Насонов Е.Л. (ред.). Российские клинические рекомендации. Ревматология. М., 2017. 464 с.
  2. Эрдес Ш., Фоломеева О.М. Проблема ревматических заболеваний в России. РМЖ. 2004;12(20):11212.
  3. Rapoport R., Kozin F., Mackel S., et al. Cutaneous vascular immunofluorescence in rheumatoid arthritis. Am. J. Med. 1980;68(3):325-31. Doi: http://dx.doi.org/10.1016/0002-9343(80)90100-X.
  4. Scott D.G., Bacon PA. Systemic rheumatoid vasculitis: a clinical and laborathory study of 50 cases. Med. (Baltimore). 1981;60(4):288-97. Doi: http://dx.doi.org/10.1097/00005792-198107000-00004.
  5. Espinoza L.R., Espinoza C.G., Vasey F.B., Germain B.F. Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations. J. Am Acad Dermatol. 1986;15(3):508-12. Doi: http://dx.doi. org/10.1016/S0190-9622(86)70202-8.
  6. Upchurch K.S., Heller K., Bress N.M. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. J. Am Acad Dermatol. 1987;17(2 Pt. 2):355-59. doi: 10.1016/s0190-9622(87)70212-6.
  7. Simon G.A., Schmid P., Reifenrath W.G., et al. Wound healing after laser injury to skin - the effect of occlusion and vitamin Eur J. Pharm Sci. 1994;83(8):1101-106. Doi: http://dx.doi. org/10.1002/jps.2600830807.
  8. Combe B., Didry C., Gutierrez M., et al. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Eur J. Med. 1993;2(3):153-56.
  9. Chen K.R., Toyohara A., Suzuki A., Miyakawa S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J. Dermatol. 2002;147(5):905-13. Doi: http:// dx.doi.org/1 0. 1 046/j. 1365-2133.2002. 04933.x.
  10. Al Attar L., Shaver T. Abatacept as a Therapeutic Option for Rheumatoid Vasculitis. Cureus. 2018;10(4):e2506. doi: 10.7759/cureus.2506.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2019

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>